TRANSFAC-Logo

TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN


AC T01689 XX ID T01689 XX DT 22.02.1996 (created); ewi. DT 21.02.2012 (updated); mkl. CO Copyright (C), QIAGEN. XX FA Staf-50 XX SY GPSTAF50; RNF94; STAF50; stimulated trans-acting factor of 50 kDa; stimulated transacting factor of 50 kDa; TRIM22; tripartite motif containing 22; tripartite motif-containing 22. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G002737 TRIM22; HGNC: TRIM22. XX CL C0049; RING. XX SF sequences and arrangement of RING finger, IM and the zinc finger-like motifs are conserved among Staf-50, Rpt-1, SS-A/RO and RFP [1]; XX CP ubiquitous, varying levels [1]. XX FF repressor (at HIV-1 LTR) [1]; FF considerable basal expression, strongly induced by IFN-gamma and -alpha/beta over 16h [1]; FF transcription of Staf50 gene is positively regulated by wt p53 [2]; FF antiproliferative effects [2]; FF induces differentiation of U937 leukemic cells [2]; XX IN T22414 atrophin-2; human, Homo sapiens. IN T19876 CIC; human, Homo sapiens. XX DR TRANSPATH: MO000025871. DR UniProtKB: Q8IYM9; XX RN [1]; RE0003822. RX PUBMED: 7797467. RA Tissot C., Mechti N. RT Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression RL J. Biol. Chem. 270:14891-14898 (1995). RN [2]; RE0025427. RX PUBMED: 15064739. RA Obad S., Brunnstrom H., Vallon-Christersson J., Borg A., Drott K., Gullberg U. RT Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. RL Oncogene 23:4050-4059 (2004). XX //